Aug 10, 2026 07:00AM
Aug 10, 2026 07:00AM
Jun 22, 2026 06:47AM
Dec 17, 2025 09:17AM
Dec 17, 2025 09:16AM
Oct 1, 2025 01:20PM
Oct 1, 2025 01:13PM FDA on Operations During Shutdown: 'FDA will not be able to accept any regulatory submissions for FY 2026 that require a fee payment'
Mar 25, 2025 04:05PM
Mar 5, 2025 08:43AM
Mar 5, 2025 08:42AM
Feb 5, 2025 06:30AM
Nov 4, 2024 07:30AM
Oct 24, 2024 06:29AM
Aug 13, 2024 04:05PM Tenax Therapeutics Reports Second Quarter 2024 Financial Results and Provides a Corporate Update
Aug 12, 2024 08:07AM
Aug 12, 2024 08:00AM
Feb 7, 2024 08:01PM
Nov 17, 2023 08:30AM
Nov 13, 2023 08:30AM
Nov 13, 2023 08:30AM
Jul 19, 2023 08:30AM Tenax Therapeutics Issued U.S. Patent for Oral Levosimendan in Pulmonary Hypertension with Heart Failure with Preserved Ejection Fraction (PH-HFpEF)
May 31, 2023 08:55AM
May 31, 2023 08:54AM
Apr 12, 2023 08:46AM
Apr 12, 2023 08:45AM
Mar 22, 2023 08:46AM
Mar 22, 2023 08:45AM
Feb 3, 2023 08:21AM Tenax Therapeutics (TENX) Prices Prices 8.67M Share Offering at $1.80/sh
Feb 3, 2023 08:19AM
Feb 1, 2023 04:37PM
Feb 1, 2023 04:31PM
Sep 15, 2022 08:34AM
Sep 15, 2022 08:30AM
May 25, 2022 08:30AM
May 23, 2022 08:30AM Tenax Therapeutics Announces Successful Comparative Pharmacokinetic Study of TNX-201 for the Treatment of Pulmonary Arterial Hypertension
May 18, 2022 08:33AM
May 18, 2022 08:30AM
Mar 31, 2022 08:30AM
Mar 30, 2022 05:00PM
Jan 31, 2022 04:13PM
Jan 31, 2022 04:10PM
Jan 12, 2022 08:33AM Tenax Therapeutics (TENX) Granted US Patent for Subcutaneous Use of Levosimendan
Jan 12, 2022 08:30AM
Jan 4, 2022 08:32AM
Jan 4, 2022 08:30AM
Nov 16, 2021 08:30AM
Oct 6, 2021 08:32AM
Oct 6, 2021 08:30AM
Sep 28, 2021 08:30AM Tenax Therapeutics to Present at the Benzinga Healthcare Small Cap Conference
May 17, 2021 05:15PM

327,899 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All